V. Spiridonenko, A. Gurgenko, A. Moroz, V. Rudakov
The study involved 70 patients with microlithiasis and chronic pyelonephritis in Art. latent course, after the minimally invasive endoscopic interventions for urolithiasis.
The subjects were divided into 3 groups according to the type of urolithiasis: the I group (n = 23), those with urate urolithiasis; II group (n = 38) with oxalate urolithiasis person; III group (n = 9) persons with phosphate urolithiasis. Control 1 consisted of 12 patients with similar phenomena ICD mixed (urate, oxalate) crystalluria, signs of CP in a latent art. No operational history, renal colic and of conservative therapy (IV group). Control 2 - consisted of 10 healthy volunteers. The average age of study 36,2 ± 2,8 years. Acceptance of cranberry concentrate (Krenfors, «Solepharm» LLC, Latvia) was conducted in the first three groups after 4 weeks. after surgery for 3 months., during the first 2 weeks. each month, per os 2 capsules a day - morning and evening. Study found that the 90 th day of the relapse rate in the I group - 4.3%, in the II - 5.2%, in the III - 0% in the IV - 83.3% .
A high risk of recurrence of infectious and inflammatory process in the urinary tract, after the endoscopic removal of stone from the ureter, can neutralize the appointment of cranberry concentrate (Krenfors) at standard doses for a period of not less than 3 months.